High Impact Hepatology Symposium

Target Audience

Gastroenterologists, Physician Assistants, Nurse Practitioners, Nurses, Pharmacists

Learning Objectives

1. To review and discuss the impact of therapy on the natural history of chronic hepatitis B and chronic hepatitis C.
2. To identify the success and limitations of treatment modalities for chronic hepatitis B and hepatitis C.
3. To integrate the latest clinical trials data into the management of individual patients in order to maximize treatment outcomes for chronic liver disease, such as autoimmune hepatitis and cholestatic diseases.
4. To learn new concepts in the management of complications of end-stage liver disease associated with these conditions, including the management of portal hypertension, hepatic encephalopathy, and hepatocellular carcinoma.